Quantitative analysis of CMTM6 expression in tumor microenvironment in metastatic melanoma and association with outcome on immunotherapy
Sandra Martínez-Morilla, Jon Zugazagoitia, Pok Fai Wong, Harriet M. Kluger, David L. Rimm
Abstract
= .028). Consequently, CMTM6 expression shows potential as a predictive factor for ICI treatments.
Topics & Concepts
Tissue microarrayImmunotherapyMedicineCD163Stromal cellMelanomaCancer researchImmune systemImmune checkpointImmunohistochemistryCD68PD-L1Cancer immunotherapyTumor microenvironmentImmunologyBiologyMacrophageIn vitroBiochemistryCancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesChemokine receptors and signaling